Concepedia

Maria‐Claudia Nascimento

MN

Statistics

Publications

3

Citations

143

H-Index

3

Active since

2007

Affiliations

ViiV Healthcare (United Kingdom)(Current)

GlaxoSmithKline (United Kingdom)

Maria‐Claudia Nascimento is an author at ViiV Healthcare (United Kingdom) specializing in clinical pharmacology, antiviral pharmacotherapy, and pharmacotherapy.

Publications per year

2007–2021

3

Publications

3

Human Herpesvirus‐8 Infection and Oral Shedding in Amerindian and Non‐Amerindian Populations in the Brazilian Amazon Region

Vanda Akico Ueda Fick de Souza, Laura Masami Sumita, Maria‐Claudia Nascimento et al. · The Journal of Infectious Diseases · 2007 · 63 citations · Full text

, , +17

Brief Report: Durable Suppression and Low Rate of Virologic Failure 3 Years After Switch to Dolutegravir + Rilpivirine 2-Drug Regimen: 148-Week Results From the SWORD-1 and SWORD-2 Randomized Clinical Trials

Jean van Wyk, Chloe Orkin, Rafael Rubio et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2020 · 50 citations · Full text

, , +17

Brief Report: Improvement in Metabolic Health Parameters at Week 48 After Switching From a Tenofovir Alafenamide–Based 3- or 4-Drug Regimen to the 2-Drug Regimen of Dolutegravir/Lamivudine: The TANGO Study

Jean van Wyk, Mounir Ait‐Khaled, Jesús Santos et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2021 · 30 citations · Full text

, , +17

1–3 of 3